Femoral Fracture Clinical Trial
Official title:
Post Market Clinical Evaluation of Gamma 4: Prospective, Multicenter, Follow-up Study (PEGASUS)
This is a prospective, multi-center, non-randomized, post-market clinical investigation of the Gamma 4 System. Neither subjects nor investigators are blinded to treatment. It is anticipated that a total of 100 subjects will be enrolled at five sites. Total duration of enrollment, 12 month follow-up and analysis is expected to take approximately 30 months. The clinical investigation has been designed to follow the surgeon's standard of care for subjects treated with a cephalomedullary nail for femoral fractures or and deformities, in addition to a 12 month follow-up visit. The primary endpoint of this clinical investigation is demonstration of bone consolidation by 12 months.
The objective of this clinical investigation is to demonstrate the safety and efficacy/performance of the Gamma 4 System. Enrolled subjects will undergo an initial assessment, with follow-up evaluations at 3 Months, 6 Months, and 12 Months after the index procedure. The primary endpoint of this clinical investigation is demonstration of bone consolidation by 12 months, as measured by the Investigator. Secondary endpoints will include safety through reporting the incidence of device related intra-operative and post-operative adverse events by 12 months, patient reported outcome measures (SF-35v2 and Modified Harris Hip Score), and other specific health outcomes. Efficacy will be assessed through non-inferiority of bone consolidation proportion compared to the pooled literature control, as well as the SF-36 score results by 12 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05515718 -
Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures
|
N/A | |
| Recruiting |
NCT04494672 -
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
|
N/A | |
| Unknown status |
NCT01680120 -
Dose Finding Study for Continuous Spinal Anaesthesia
|
Phase 4 | |
| Recruiting |
NCT04015128 -
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
|
||
| Active, not recruiting |
NCT04015154 -
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF
|
||
| Recruiting |
NCT05410587 -
Fracture Monitor - Femur
|
N/A | |
| Completed |
NCT02983344 -
Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia
|
N/A | |
| Terminated |
NCT00764959 -
Retrospective Study of the Linear™ Hip
|
Phase 4 | |
| Completed |
NCT02069327 -
The Role of Fat Emboli in the Trauma Inflammatory Response
|
||
| Completed |
NCT03856502 -
Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures
|
N/A | |
| Recruiting |
NCT05559736 -
Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures
|
N/A | |
| Completed |
NCT03810092 -
Analysis of the Relationship Between Early Postoperative Anemia and the Evolution of Autonomy at 6 Months in Patients 75 Years of Age and Older Operated on Following a Fracture of the Upper End of the Femur
|
||
| Recruiting |
NCT05087667 -
Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
|
N/A | |
| Recruiting |
NCT05274022 -
Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture
|
N/A | |
| Terminated |
NCT01300520 -
The Development of a Surgical Localizing Aid Medical Device
|
N/A | |
| Terminated |
NCT01141894 -
Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture
|
N/A | |
| Recruiting |
NCT05668182 -
A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects
|
||
| Recruiting |
NCT05680987 -
Retrograde Femoral Nail-Advanced Outcomes for Fixation of Distal Femur and Femoral Shaft Fractures
|
N/A | |
| Not yet recruiting |
NCT04918680 -
Prospective Post-market Study Examining the Effectiveness of the EcoFit®
|
||
| Terminated |
NCT03846102 -
MORphine Use in the Fascia Iliaca Compartment Block With UltraSound
|
Phase 4 |